Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies

The International Collaboration of Epidemiological Studies of Cervical Cancer has combined individual data on 11,161 women with invasive carcinoma, 5,402 women with cervical intraepithelial neoplasia (CIN)3/carcinoma in situ and 33,542 women without cervical carcinoma from 25 epidemiological studies. Relative risks (RRs) and 95% confidence intervals (CIs) of cervical carcinoma in relation to number of full‐term pregnancies, and age at first full‐term pregnancy, were calculated conditioning by study, age, lifetime number of sexual partners and age at first sexual intercourse. Number of full‐term pregnancies was associated with a risk of invasive cervical carcinoma. After controlling for age at first full‐term pregnancy, the RR for invasive cervical carcinoma among parous women was 1.76 (95% CI: 1.53–2.02) for ≥≥7 full‐term pregnancies compared with 1–2. For CIN3/carcinoma in situ, no significant trend was found with increasing number of births after controlling for age at first full‐term pregnancy among parous women. Early age at first full‐term pregnancy was also associated with risk of both invasive cervical carcinoma and CIN3/carcinoma in situ. After controlling for number of full‐term pregnancies, the RR for first full‐term pregnancy at age <17 years compared with ≥≥25 years was 1.77 (95% CI: 1.42–2.23) for invasive cervical carcinoma, and 1.78 (95% CI: 1.26–2.51) for CIN3/carcinoma in situ. Results were similar in analyses restricted to high‐risk human papilloma virus (HPV)‐positive cases and controls. No relationship was found between cervical HPV positivity and number of full‐term pregnancies, or age at first full‐term pregnancy among controls. Differences in reproductive habits may have contributed to differences in cervical cancer incidence between developed and developing countries. © 2006 Wiley‐Liss, Inc.

[1]  R. Fruchter,et al.  Oral contraceptives and cervical carcinoma. , 1977, American journal of obstetrics and gynecology.

[2]  C. la Vecchia,et al.  Reproductive factors and the risk of invasive and intraepithelial cervical neoplasia. , 1989, British Journal of Cancer.

[3]  K. Ebeling,et al.  Use of oral contraceptives and risk of invasive cervical cancer in previously screened women , 1987, International journal of cancer.

[4]  S. Franceschi,et al.  Cervical carcinoma in Algiers, Algeria: Human papillomavirus and lifestyle risk factors , 2005, International journal of cancer.

[5]  B. Henderson,et al.  Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. , 1986, Journal of the National Cancer Institute.

[6]  R. Seamark,et al.  CHANGES IN LYMPHOCYTE FUNCTION DURING PREGNANCY , 1976, British journal of obstetrics and gynaecology.

[7]  J. Cuzick,et al.  Risk factors for invasive cervix cancer in young women. , 1996, European journal of cancer.

[8]  H. Nakshatri,et al.  Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA , 1988, Nature.

[9]  L. Rosero-Bixby,et al.  Sexual Behavior, Sexually Transmitted Diseases, and Risk of Cervical Cancer , 1995, Epidemiology.

[10]  L. Kuller,et al.  Refining Preventive Strategies for Invasive Cervical Cancer: A Population-Based Case-Control Study , 1995 .

[11]  E. Wynder,et al.  A study of environmental factors in carcinoma of the cervix. , 1954, American journal of obstetrics and gynecology.

[12]  D. Thomas,et al.  Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. , 1996, American journal of epidemiology.

[13]  V. Beral,et al.  Cervical cancer and use of hormonal contraceptives: a systematic review , 2003, The Lancet.

[14]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[15]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[16]  N. Muñoz,et al.  HPV types and cofactors causing cervical cancer in Peru , 2001, British Journal of Cancer.

[17]  M P Vessey,et al.  Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–Control Study of Cervical Cancer , 2003, British Journal of Cancer.

[18]  K. Zondervan,et al.  Oral contraceptives and cervical cancer--further findings from the Oxford Family Planning Association contraceptive study. , 1996, British Journal of Cancer.

[19]  H. Adami,et al.  Smoking and oral contraceptives as risk factors for cervical carcinoma In situ , 1999, International journal of cancer.

[20]  N. Muñoz,et al.  The viral origin of cervical cancer in Rabat, Morocco , 1998, International journal of cancer.

[21]  S. Shapiro,et al.  Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) , 2003, Cancer Causes & Control.

[22]  D. Thomas.  An epidemiologic study of carcinoma in situ and squamous dysplasia of the uterine cervix. , 1973, American journal of epidemiology.

[23]  S. You,et al.  Reproductive and infectious risk factors for invasive cervical cancer in Taiwan. , 1999, Anticancer research.

[24]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[25]  S. Franceschi,et al.  Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case‐control study , 2003, International journal of cancer.

[26]  J. Cuzick,et al.  Case-control study of risk factors for cervical intraepithelial neoplasia in young women. , 1990, European journal of cancer.

[27]  M. Sherman,et al.  Sexual Behavior, Human Papillomavirus Type 16 (HPV 16) Infection, and HPV 16 Seropositivity , 2002, Sexually transmitted diseases.

[28]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[29]  D. Skegg.  Oral contraceptives, parity, and cervical cancer , 2002, The Lancet.

[30]  I. D. Rotkin.  The Uterus: ADOLESCENT COITUS AND CERVICAL CANCER ASSOCIATIONS OF RELATED EVENTS WITH INCREASED RISK , 1968 .

[31]  The ESUB-MG Study Group.  The Million Women Study: design and characteristics of the study population , 1999, Breast Cancer Research.

[32]  S. Wacholder,et al.  HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica , 2001, British Journal of Cancer.

[33]  B. Modan,et al.  Invasive squamous‐cell cervical carcinoma and combined oral contraceptives: Results from a multinational study , 1993 .

[34]  B. D. Stavola,et al.  Statistical facts about cancers on which doctor Rigoni‐stern based his contribution to the Surgeons' Subgroup of the IV Congress of the Italian Scientists on 23 September 1842 , 1987 .

[35]  R. Doll,et al.  A Study of the Aetiology of Carcinoma of the Cervix Uteri , 1964, British Journal of Cancer.

[36]  Rigoni-Stern.  Statistical facts about cancers on which Doctor Rigoni-Stern based his contribution to the Surgeons' Subgroup of the IV Congress of the Italian Scientists on 23 September 1842. (translation) , 1987, Statistics in medicine.

[37]  C. la Vecchia,et al.  Trends in uterine cancer mortality in the Americas, 1955-1988. , 1993, Gynecologic oncology.

[38]  P. Porter,et al.  Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  F. X. Bosch,et al.  Risk factors for cervical cancer in Thailand: a case-control study. , 1998, Journal of the National Cancer Institute.

[40]  P. Coursaget,et al.  Risk factors of invasive cervical cancer in Mali. , 2002, International journal of epidemiology.

[41]  J. Fortney,et al.  Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association? , 1988, JAMA.

[42]  B. Thomsen,et al.  Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study , 2002, BMJ : British Medical Journal.

[43]  D. Celentano,et al.  The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study. , 1987, American journal of epidemiology.

[44]  L. Brinton,et al.  Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. , 2003, American journal of obstetrics and gynecology.

[45]  B. Steinberg.  Papillomavirus , 2022, CABI Compendium.

[46]  Valerie Beral,et al.  Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study , 1999, BMJ.

[47]  T. French,et al.  Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. , 1989, JAMA.

[48]  S. Kjaer,et al.  Case-control study of risk factors for cervical neoplasia in Denmark. II. Role of sexual activity, reproductive factors, and venereal infections , 1992, Cancer Causes & Control.

[49]  R. Walker,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2005 .

[50]  L. Brinton,et al.  Parity as a risk factor for cervical cancer. , 1989, American journal of epidemiology.

[51]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.

[52]  J. Peto,et al.  Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort , 2000, British Journal of Cancer.

[53]  S. Schwartz,et al.  The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  M. Pike,et al.  Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States) , 1996, Cancer Causes & Control.

[55]  M. Plummer.  Improved estimates of floating absolute risk , 2004, Statistics in medicine.

[56]  N. Muñoz,et al.  Human papillomavirus infection and invasive cervical cancer in Paraguay , 2000, International journal of cancer.

[57]  I. Gram,et al.  Cigarette smoking and the incidence of cervical intraepithelial neoplasia, grade III, and cancer of the cervix uteri. , 1992, American journal of epidemiology.

[58]  J. Dillner,et al.  A population-based study of cervical carcinoma and HPV infection in Latvia. , 2004, Gynecologic oncology.

[59]  I. Romieu,et al.  [Reproductive risk factors and sexual history associated with cervical cancer in Mexico]. , 1995, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[60]  J. Fraumeni,et al.  Sexual and reproductive risk factors for invasive squamous cell cervical cancer. , 1987, Journal of the National Cancer Institute.

[61]  F. X. Bosch,et al.  Causes of cervical cancer in the Philippines: a case-control study. , 1998, Journal of the National Cancer Institute.

[62]  J. Kaldor,et al.  Risk factors for cervical cancer in Colombia and Spain , 1992, International journal of cancer.

[63]  F. X. Bosch,et al.  Human papillomavirus and invasive cervical cancer in Brazil. , 1994, British Journal of Cancer.

[64]  K. Stone,et al.  Human papillomavirus infection and genital warts: update on epidemiology and treatment. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  N. Kiviat,et al.  Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. , 2001, American journal of epidemiology.

[66]  F. X. Bosch,et al.  Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[67]  R. Ray,et al.  Oral Contraceptives and Invasive Adenocarcinomas and Adenosquamous Carcinomas of the Uterine Cervix , 1996 .

[68]  V. Beral,et al.  The spectrum of HIV‐1 related cancers in South Africa , 2000, International journal of cancer.

[69]  V. Moreno,et al.  Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study , 2002, The Lancet.